Loading…
InBios International, Inc. designs, develops, and manufactures immunodiagnostic tests for infectious diseases, including FDA-cleared respiratory diagnostics and tests for emerging diseases like Dengue, West Nile, and Zika. The company also provides contract services and assay development, with all products made in its Seattle facility under GMP, FDA, and ISO 13485:2016 certifications.
AI named InBios International, Inc. from December 2025 to January 2026.